>
AdaptaArbo Study

CRF version 1.0 of 27/12/2025
Protocol AdaptaArbo

Product: Molnupiravir
Adaptive Evaluation of Arbovirus Treatments (Adapta-Arbo): A Placebo-Controlled, Double-blind, Randomized, Adaptive Trial to Evaluate the Pharmacodynamics of Molnupiravir in Symptomatic and Early Chikungunya and Dengue Infections
 
Copyright © 2025 Informapro S.R.L. - TUTTI I DIRITTI RISERVATI
per contatti riguardanti lo Studio AdaptaArbo mailto:avithrapid@ipro-it.eu